The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Combined epiregulin (EREG) and amphiregulin (AREG) expression levels as a biomarker of prognosis and panitumumab benefit in RAS-wt advanced colorectal cancer (aCRC).
Jenny F. Seligmann
No relevant relationships to disclose
Faye Elliott
No relevant relationships to disclose
Susan Richman
No relevant relationships to disclose
Bart Jacobs
No relevant relationships to disclose
Gemma Hemmings
No relevant relationships to disclose
Jenny Barrett
No relevant relationships to disclose
Sabine Tejpar
No relevant relationships to disclose
Philip Quirke
No relevant relationships to disclose
Matthew T. Seymour
No relevant relationships to disclose